日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance

APOBEC3B在肺肿瘤演变和靶向癌症治疗耐药性中的作用

Deborah R Caswell #,Philippe Gui #,Manasi K Mayekar #,Emily K Law,Oriol Pich,Chris Bailey,Jesse Boumelha,D Lucas Kerr,Collin M Blakely,Tadashi Manabe,Carlos Martinez-Ruiz ,Bjorn Bakker,Juan De Dios Palomino Villcas,Natalie I Vokes ,Michelle Dietzen ,Mihaela Angelova,Beatrice Gini,Whitney Tamaki,Paul Allegakoen,Wei Wu,Timothy J Humpton ,William Hill,Mona Tomaschko,Wei-Ting Lu,Franziska Haderk,Maise Al Bakir,Ai Nagano,Francisco Gimeno-Valiente,Sophie de Carné Trécesson,Roberto Vendramin,Vittorio Barbè,Miriam Mugabo,Clare E Weeden,Andrew Rowan,Caroline E McCoach,Bruna Almeida ,Mary Green,Carlos Gomez,Shigeki Nanjo,Dora Barbosa,Chris Moore,Joanna Przewrocka,James R M Black ,Eva Grönroos,Alejandro Suarez-Bonnet ,Simon L Priestnall ,Caroline Zverev,Scott Lighterness,James Cormack,Victor Olivas,Lauren Cech,Trisha Andrews,Brandon Rule , Yuwei Jiao , Xinzhu Zhang , Paul Ashford , Cameron Durfee , Subramanian Venkatesan,Nuri Alpay Temiz  ,Lisa Tan,Lindsay K Larson,Prokopios P Argyris,William L Brown,Elizabeth A Yu  ,Julia K Rotow , Udayan Guha  ,Nitin Roper , Johnny Yu , Rachel I Vogel , Nicholas J Thomas,Antonio Marra , Pier Selenica , Helena Yu  ,Samuel F Bakhoum  ,Su Kit Chew,Jorge S Reis-Filho , Mariam Jamal-Hanjani,Karen H Vousden,Nicholas McGranahan ,Eliezer M Van Allen , Nnennaya Kanu,Reuben S Harris  ,Julian Downward,Trever G Bivona  ,Charles Swanton

Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer

粘着斑激酶-YAP信号轴驱动肺癌中耐药持久细胞和残留疾病

Franziska Haderk #, Yu-Ting Chou #, Lauren Cech #, Celia Fernández-Méndez, Johnny Yu, Victor Olivas, Ismail M Meraz, Dora Barbosa Rabago, D Lucas Kerr, Carlos Gomez, David V Allegakoen, Juan Guan, Khyati N Shah, Kari A Herrington, Oghenekevwe M Gbenedio, Shigeki Nanjo, Mourad Majidi, Whitney Tamaki,

AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer

AXL 和易出错的 DNA 复制赋予耐药性并为治疗 EGFR 突变型肺癌提供策略

Ashish Noronha, Nishanth Belugali Nataraj, Joo Sang Lee, Benny Zhitomirsky, Yaara Oren, Sara Oster, Moshit Lindzen, Saptaparna Mukherjee, Rainer Will, Soma Ghosh, Arturo Simoni-Nieves, Aakanksha Verma, Rishita Chatterjee, Simone Borgoni, Welles Robinson, Sanju Sinha, Alexander Brandis, D Lucas Kerr,

Small-molecule targeted therapies induce dependence on DNA double-strand break repair in residual tumor cells

小分子靶向治疗诱导残留肿瘤细胞对 DNA 双链断裂修复的依赖

Moiez Ali, Min Lu, Hazel Xiaohui Ang, Ryan S Soderquist, Christine E Eyler, Haley M Hutchinson, Carolyn Glass, Christopher F Bassil, Omar M Lopez, D Lucas Kerr, Christina J Falcon, Helena A Yu, Aaron N Hata, Collin M Blakely, Caroline E McCoach, Trever G Bivona, Kris C Wood

Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer

剪接因子 RBM10 的缺乏限制了 EGFR 突变肺癌中 EGFR 抑制剂的反应

Shigeki Nanjo, Wei Wu, Niki Karachaliou, Collin M Blakely, Junji Suzuki, Yu-Ting Chou, Siraj M Ali, D Lucas Kerr, Victor R Olivas, Jonathan Shue, Julia Rotow, Manasi K Mayekar, Franziska Haderk, Nilanjana Chatterjee, Anatoly Urisman, Jia Chi Yeo, Anders J Skanderup, Aaron C Tan, Wai Leong Tam, Oscar

Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing

单细胞RNA测序揭示治疗诱导的人类肺癌演变

Ashley Maynard,Caroline E McCoach,Julia K Rotow,Lincoln Harris,Franziska Haderk,D Lucas Kerr,Elizabeth A Yu,Erin L Schenk,Weilun Tan,Alexander Zee,Michelle Tan,Philippe Gui,Tasha Lea,Wei Wu,Anatoly Urisman,Kirk Jones,Rene Sit,Pallav K Kolli,Eric Seeley,Yaron Gesthalter,Daniel D Le,Kevin A Yamauchi,David M Naeger,Sourav Bandyopadhyay,Khyati Shah,Lauren Cech,Nicholas J Thomas,Anshal Gupta,Mayra Gonzalez,Hien Do,Lisa Tan,Bianca Bacaltos,Rafael Gomez-Sjoberg,Matthew Gubens,Thierry Jahan,Johannes R Kratz,David Jablons,Norma Neff,Robert C Doebele,Jonathan Weissman,Collin M Blakely,Spyros Darmanis,Trever G Bivona